HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by DF Dent & Co. Inc.

DF Dent & Co. Inc. trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.1% during the fourth quarter, HoldingsChannel reports. The fund owned 287,330 shares of the company’s stock after selling 9,249 shares during the quarter. DF Dent & Co. Inc.’s holdings in HealthEquity were worth $27,569,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in HQY. Wealthfront Advisers LLC purchased a new stake in shares of HealthEquity during the 4th quarter worth $10,304,089,000. Norges Bank acquired a new stake in shares of HealthEquity in the fourth quarter valued at about $74,701,000. Raymond James Financial Inc. purchased a new stake in HealthEquity during the fourth quarter worth about $45,728,000. Artisan Partners Limited Partnership acquired a new position in HealthEquity during the fourth quarter worth about $24,568,000. Finally, Geneva Capital Management LLC grew its position in HealthEquity by 24.6% during the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after buying an additional 206,894 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. The Goldman Sachs Group cut their price target on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research note on Thursday, March 27th. Finally, Royal Bank of Canada boosted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $112.58.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.20% of the stock is owned by corporate insiders.

HealthEquity Trading Up 1.9 %

HealthEquity stock opened at $88.74 on Thursday. The stock has a 50-day moving average price of $102.66 and a 200 day moving average price of $96.30. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The stock has a market cap of $7.68 billion, a PE ratio of 81.41, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.